Clinical Trial Update: CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial of GCAR1 CAR T therapy for relapsed alveolar soft part sarcoma is ongoing, sponsored by the University of Calgary, with status listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma

Drugs mentioned

• GCAR1

Snippet

Sponsor: University of Calgary | Conditions: Sarcoma, Alveolar Soft Part Sarcoma (ASPS) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING